CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Context Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.24−0.01 (-2.30%)
Close on Oct 19, 2026
- Market cap
- $22.69M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Context Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | May 1, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 28, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 24, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 17, 2025 | Oct 20, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2025 | Sep 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2025 | Apr 9, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2025 | Jan 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 2, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 23, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2024 | Sep 17, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2024 | Sep 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 17, 2024 | Jul 24, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2024 | Jul 10, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 14, 2024 | SEC EDGAR |